Autochthonous leprosy in metropolitan France presenting with a diffuse infiltration of the face and febrile illness

International Journal of Dermatology

Volumn 48, Issue 1, 2009, Pages 69-72

  Ezzedine, Khaled ^a,b   Malvy, Denis ^a,b   Beylot, Claire ^a,b   Longy Boursier, Maïté ^a,b  

^a HÔPITAL SAINT ANDRÉ   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; CORTICOSTEROID; DAPSONE; PREDNISONE; RIFAMPICIN; THALIDOMIDE;

ACID FAST BACTERIUM; ADULT; ARTICLE; AXONAL INJURY; CASE REPORT; CLINICAL FEATURE; DISABILITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; ELECTROPHYSIOLOGY; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FACE; FATIGUE; FEMALE; FEVER; FRANCE; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LABORATORY TEST; LEG; LEPROMATOUS LEPROSY; MACULOPAPULAR RASH; MONOTHERAPY; MOUTH; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PUNCH BIOPSY; RELAPSE; SENSORY DYSFUNCTION; SKIN MANIFESTATION; SKIN NODULE; SKIN ULCER; TREATMENT DURATION; VASCULITIS; WEAKNESS;

BIOPSY, NEEDLE; CLOFAZIMINE; DAPSONE; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FACIAL DERMATOSES; FEMALE; FEVER; FOLLOW-UP STUDIES; FRANCE; HUMANS; IMMUNOHISTOCHEMISTRY; LEG DERMATOSES; LEPROSY, LEPROMATOUS; MIDDLE AGED; RIFAMPIN; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 58149305655     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.03831.x     Document Type: Article

References (13)

1. Flageul B. Epidemiology study of Hansen's disease in metropolitan France between 1995 and 1998. Ann Dermatol Venereol 2001; 128: 17-20.
2. Britton WJ, Lockwood DNJ. Leprosy. Lancet 2004; 363: 1209-1219.
3. Alfonso JL, Vich FA, Vilata JJ, et al. Factors contributing to the decline of leprosy in Spain in the second half of the twentieth century. Int J Lepr Other Mycobact Dis 2005; 73: 258-268.
4. Sequeira J, Martins C, Marques C, et al. Leprosy. Comparative study of old and new patients. Acta Med Port 2000; 13: 13-17.
5. Brubaker ML, Binford CH, Trautman JR. Occurrences of leprosy US veterans after service in endemic areas abroad. Public Health Rep 1969; 84: 1051-1058.
6. Magdorf K, Haas WH, Harms D, et al. Leprosy. An overview from a pediatric perspective. Klin Pediatr 2001; 213: 266-270.
7. Cormier-Lebreton MN, Celerier P, Pasquiou C. Autochtonal leprosy. Ann Dermatol Venereol 1995; 122: 606-608.
8. Cottenot F, Merklen FP. Autochtonous leprosy in metropolitan France. Dermatol Int 1968; 7: 46-47.
9. Weng XM, Chen SY, Ran SP, et al. Immunohistopathology in the diagnosis of early leprosy. Int J Lepr Other Mycobact Dis 2000; 68: 426-433.
10. Moschella SL. An update on the diagnosis and treatment of leprosy. J Am Acad Dermatol 2004; 51: 417-426.
11. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Leprosy 1966; 34: 255-273.
12. Rea TH. Lucio's phenomenon: An overview. Lepr Rev 1979; 50: 107-112.
13. Guerra JG, Penna GO, de Castro LC, et al. Erythema nodosum leprosum: clinical and therapeutic update. An Bras Dermatol 2002; 77: 389-407.